opening possibilities for improvement of care. According to Ray Dorsey, MD, David M. Levy Professor of Neurology and Director of CHET at the University of Rochester Medical Center, the wider adoption of increasingly refined technology may lead to the development of sensitive outcome measures, particularly in Parkinson’s disease, which would not only improve research but healthcare delivery, as well. In fact, the goal of developing these improved outcomes measures is to replace the “currently categorical, subjective, and largely insensitive in-clinic outcome measures,” says Dr. Dorsey.